JPRN-UMIN000004650已完成未知
Evaluation of Usefulness of ONS (Oral Nutritional Supplement) in Postoperative Patients with Gastric Cancer - Evaluation of Usefulness of ONS (Oral Nutritional Supplement) in Postoperative Patients with Gastric Cancer
THE UNIVERSITOY OF TOKYO0 个研究点目标入组 150 人开始时间: 2010年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with ileus 2)Patients with no residual intestinal function 3)Patients with severe liver disorder AST (GOT) or ALT (GPT) ≥ 2.5 times the upper limit of normal at hospital 4)Patients with severe renal disorder Cr ≥ 2.0 mg/dL 5)Patients with abnormal glucose metabolism such as severe diabetes mellitus : HbA1c ≥ 7.0% 6)Patients with allergy to any ingredient of milk, wheat, soy bean, or salmon 7)Pregnant women, women suspected of being pregnant, or lactating women 8)Patients with active double cancer and/or multiple cancer
研究者
相似试验
招募中
2 期
The effect of oral nutrition supplement (ONS) on autologous hematopoietic stem cell transplantatioMultiple myelomaCondition 1: Lymphoma. Condition 2: multiple myeloma.Non-Hodgkin lymphoma, unspecifiedC85.9C90.0IRCT20220208053971N2Tehran University of Medical Sciences38
已完成
3 期
A study of an oral nutrition supplement (ONS) in childreCTRI/2014/07/004717Abbott Nutrition International India256
招募中
不适用
The effect of oral nutritional supplement (ONS) on the prognostic nutritional index (PNI) during neoadjuvant chemotherapy for gastric cancergastric cancerJPRN-UMIN000012598ara Medical University40
招募中
2 期
The efficacy of oral nutritional therapy with ENORAS for the patients after gastrectomy and the evaluation for the nutritional index: exploratory prospective studyGastric cancerJPRN-UMIN000047451Kobe University50
招募中
不适用
The effects of oral nutritional supplement (ONS) during chemoradiotherapy in patients with pancreatic and/or esophageal cancerPatients with pancreatic and/or esophageal cancer, who are scheduled to receive chemoradiotherapyJPRN-UMIN000006274Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology50